ASXL1 mutations are related to unique epigenomic alterations that result in sensitivity to venetoclax and azacytidine . Simply because a affected individual has an SNP that might predispose them to impaired methylation won't necessarily mean they actually have impaired methylation. Proposed mechanism of motion of DNA methylation inhibitors in cancer https://bernieb948hvh8.losblogos.com/profile